A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

Recruiting now · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus

In brief

A Phase 1/2a Study of DB-2304 in Healthy Participants and Participants with Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus

Key facts

Study ID

NCT06625671

Run by

DualityBio Inc.

People needed

148

Starts

2024-10-04

Expected to finish

2027-12-30

Last updated by the study team

2026-06-02

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

Where it is running

• US02-0 — San Antonio, Texas, United States (enrolling)
• US03-0 — Clearwater, Florida, United States (enrolling)
• US05-0 — Orlando, Florida, United States (enrolling)
• US06-0 — La Palma, California, United States (enrolling)
• US04-0 — Irving, Texas, United States (enrolling)
• US08-0 — Syracuse, New York, United States
• Site AUS01-0 — Melbourne, Victoria, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.